Organization
Assistance Publique Hôpitaux de Paris (AP-HP)
1 abstract
Abstract
Immune features of ovarian tumors with a good response to neo-adjuvant chemotherapy in combination with an anti-PD-L1 alone or with an anti-CTLA4: Data from the randomized IneOV trial (a GINECO study).Org: Gustave-Roussy Cancer Campus, GINECO-Centre Jean Perrin, Clermont-Ferrand, France, Gustave Roussy Cancer Center, INSERM U981 GUSTAVE ROUSSY, Centre Catherine de Sienne,